Pilot Chart Review Study Of Sitaxentan Sodium (Thelin) In Patients With Pulmonary Arterial Hypertension (PAH)

NCT01445873 · clinicaltrials.gov ↗

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG: Sitaxentan sodium

Sponsor

Pfizer